Treatment of acute ischemic brain infarction with the assistance of local intraarterial thrombolysis with recombinant tissue-type plasminogen activator

Acta Radiologica

Volumn 48, Issue 7, 2007, Pages 774-780

  Poncyljusz, W ^a   Falkowski, A ^b   Kojder, I ^b   Cebula, E ^b   Sagan, L ^b   Czechowski, J ^b   Walecka, A ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b SPSK 1 ^*

Author keywords

Acute ischemic stroke; Local intraarterial thrombolysis

Indexed keywords

ANGIOGRAPHY; BRAIN; COMPUTERIZED TOMOGRAPHY; MEDICAL PROBLEMS; TISSUE;

ACUTE ISCHEMIC STROKE; DIGITAL SUBTRACTION ANGIOGRAPHY (DSA); LOCAL INTRAARTERIAL THROMBOLYSIS; MIDDLE CEREBRAL ARTERY (MCA);

PATIENT TREATMENT;

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; CEREBRAL ARTERY DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 34548332519     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850701408228     Document Type: Article

References (28)

1. Adams HP Jr. Emergent use of anticoagulation for treatment of patients with ischemic stroke. Stroke 2002;33:856-61.
2. Albers GW. Expanding the time window for thrombolytic therapy in acute stroke. The potential MRI trial role of acute MRI for patient selection. Stroke 1999;30:2230-7.
3. Albers GW, Clark WM, Madden KP, Hamilton SA. ATLANTIS trial: results for patients treated within 3 hours of stroke onset: alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. Stroke 2002;33:493-6.
4. American Heart Association, Heart and stroke facts statistics: 1999 statistical supplement. Dallas: American Heart Association, 1999.
5. Arnold M, Schroth G, Nedeltchev K, Loher T, Remonda L, Stepper F, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion, Stroke 2002;33:1828-33.
6. Berlis A, Lutsep H, Barnwell S, Norbash A, Wechsler L, Jungreis CA, et al. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 2004;35:1112-6.
7. Clark WM, Albers GW, Madden KP, Hamilton S. The rt-PA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study: thrombolytic therapy in acute ischemic stroke study investigators. Stroke 2000;31:811-6.
8. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: a randomized controlled trial: alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 1999;282:2019-26.
9. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators: prolyse in acute cerebral thromboembolism. Stroke 1998;29:4-11.
10. Eckert B, Kuciński T, Neumaier-Probst E, Fiehler J, Röther J, Zeumer H. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalisation success and neurological outcome. Cerebrovasc Dis 2003;15:258-63.
11. Furlan AJ, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA 1999;282:2003-11.
12. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51.
13. Higashida RT, Cullen S P, Malek R, Dowd C F, Halbach VV. Intraarterial thrombolysis trials in acute ischemic stroke. J Vase Interv Radiol 2004;15:S77-85.
14. Higashida R T, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:109-37.
15. Lewandowski C, Frankel M, Tomsick T, Frey J, Clark W, Starkman S, et al. The EMS Bridging Trial Investigators. Combined intravenous and intra-arterial r-tPA verses intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-605.
16. Mangiafico S, Cellerini M, Nencini P, Gensini G, Inzitari D. Intravenous glycoprotein Ilb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. Am J Neuroradiol 2005;26:2595-601.
17. Mangiafico S, Cellerini M, Nencini P, Gensini G, Inzitari D. Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases. Stroke 2005;36:2154-8.
18. Noser EA, Shaltoni HM, Hall CE, Alexandrov AV, Garami Z, Cacayorin ED, et al. Campbell III aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005;36:292-6.
19. Oppenheim C, Naggara O, Arquizan C, Brami-Zylberberg F, Mas J, Meder L, et al. MRI of acute ischemic stroke. J Radiol 2005;86:1069-78.
20. Poncyljusz W, Cyryłowski L, Sagan L, Falkowski A, Posio V. Local intra-arterial fibrinolysis in a treatment of the acute ischemic stroke. Pol J Radiol 2003;68:90-7.
21. Randall T, Higashida R T, Furlan A J. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:1923-4.
22. Ringer AJ, Qureshi AI, Fessler RD, Guterman LR, Hopkins LN. Angioplasty for intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001;48:1282-8.
23. Röther J, Schellinger P, Gass A, Siebler M, Villringer A, Siebler M, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6h. Stroke 2002;33:2438-45.
24. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8.
25. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
26. Wintermark M. Brain perfusion-CT in acute stroke patients. Eur Radiol 2005;15 Suppl 4:D28-31.
27. Versnick EJ, Do HM, Albers GW, Tong DC, Marks MP. Mechanical thrombectomy for acute stroke. Am J Neuroradiol 2005;26:875-9.
28. Von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992;23:646-52.